Pirouette Pharma — investors & funding

Investors

13 investors

All

Early stage

Mid stage

Late stage

Seed investors· 1

Thomas Mueller, MSIS

Visionary Data & Analytics Leader ● former Chief Data Officer (CDO) ● Platform Modernization, M&A, AI Enablement, Cost Optimization ● Consultant ● Early-Stage Investor ● Public Speaker

Early stage· 2

Investor & Mentor Startup Strategy and Bus. Dev.

early stage

May 2017

Mid stage· 2

Consultant • Start-Up Advisor • Entrepreneur

Healthcare Investor and Consultant

Late stage· 8

Co-Founder & CEO | Working on what comes next in AI

Operations @ Soliddd Corp

late stage

Aug 2024

Sam Williams

Capital Markets at Montecito Medical Real Estate

Sustainable Finance, ESG & Responsible Investment | Investor in Deep Tech & Climate | Views are Personal

Logistics Specialist at FB Solutions Group

International Arbitration Lawyer | Building Donna AI® - the world’s first AI-native legal OS.

Product Builder | Fractional Head of Product | ex-Alan, ex-Uber | Founder (1 exit)

late stage

8 investments

2024

Investor geography4 countries

United States

United Kingdom

France

Australia

Investor activity2017–2025 · investors recorded per year

Recent (last 2y)Earlier

Frequently asked questions

Who invested in Pirouette Pharma?

Pirouette Pharma has 13 investors on record on gritt.io, including 2 early-stage backers, 2 mid-stage and 9 late-stage investors.

When did Pirouette Pharma last raise funding?

The most recent investment in Pirouette Pharma recorded on gritt.io was in February 2025.

When was Pirouette Pharma founded?

Pirouette Pharma was founded in 2017.

What industry is Pirouette Pharma in?

Pirouette Pharma operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.

Where is Pirouette Pharma based?

Pirouette Pharma is headquartered in Portsmouth, United States.